肝激素和MASLD:GLP1-Ras-FGF21-Fetuin-A交叉作为一个治疗目标

Ilaria Milani1, Michela Codini2, Gloria Guarisco1

  • 1Department of Medico-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, University of Rome La Sapienza, 04100 Latina, Italy.

概括

代谢性脂肪性肝病 (MASLD) 涉及代谢功能障碍. 纤维细胞生长因子21 (FGF21) 和 fetuin-A 是关键的肝激素,它们通过 GLP1-R 激素的调节可以治疗 MASLD.